KREBS BioChem21/07/2024
KREBS BioChem
CMP: 110.88
Target: 125-150-185
SL:95
Information is only for study purpose
−10.09 INR
−197.28 M INR
507.16 M INR
About KREBS BIOCHEMICALS & IND
Sector
CEO
Jitendra Shah
Headquarters
Hyderabad
Website
Founded
1991
ISIN
INE268B01013
FIGI
BBG000DC0HZ2
Krebs Biochemicals & Industries Ltd. engages in the manufacture and sale of pharmaceutical ingredients and intermediates. Its products include Androstenedione, Lovastatin, and Simvastatin. The company was founded by Ravindranath Tagore Ravi on December 2, 1991, and is headquartered in Hyderabad, India.
krebsKrebs Biochemicals & Industries (KBIL) was established in the year 1991 as a Public Limited Company with the main objective of establishing commercially viable biotech processes with applications in Medicine, Agriculture Industry. The company has pioneered in the fermentation technology over the las
KREBSKrebs bio double bottom formation. If the trend line breaks above it will reach the target . Only for positional
Bullish NSE:KREBSBIOBuy = 180
SL = 168.55
Target 1 = 202.9
Target 2 = 214.35
17/09/2021
Bullish NSE:KREBSBIO-->Krebs Biochemicals And Industries Ltd
Buy for short term
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of KREBSBIO is 85.12 INR — it has decreased by −0.07% in the past 24 hours. Watch KREBS BIOCHEMICALS & IND stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange KREBS BIOCHEMICALS & IND stocks are traded under the ticker KREBSBIO.
KREBSBIO stock has fallen by −4.63% compared to the previous week, the month change is a 4.12% rise, over the last year KREBS BIOCHEMICALS & IND has showed a 1.64% increase.
KREBSBIO reached its all-time high on Mar 11, 1999 with the price of 253.02 INR, and its all-time low was 50.65 INR and was reached on Mar 29, 2023. View more price dynamics on KREBSBIO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
KREBSBIO stock is 7.89% volatile and has beta coefficient of 1.43. Track KREBS BIOCHEMICALS & IND stock price on the chart and check out the list of the most volatile stocks — is KREBS BIOCHEMICALS & IND there?
Today KREBS BIOCHEMICALS & IND has the market capitalization of 1.81 B, it has increased by 10.17% over the last week.
Yes, you can track KREBS BIOCHEMICALS & IND financials in yearly and quarterly reports right on TradingView.
KREBSBIO net income for the last quarter is −57.61 M INR, while the quarter before that showed −51.71 M INR of net income which accounts for −11.40% change. Track more KREBS BIOCHEMICALS & IND financial stats to get the full picture.
No, KREBSBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 14, 2024, the company has 191.00 employees. See our rating of the largest employees — is KREBS BIOCHEMICALS & IND on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KREBS BIOCHEMICALS & IND EBITDA is −101.10 M INR, and current EBITDA margin is −16.62%. See more stats in KREBS BIOCHEMICALS & IND financial statements.
Like other stocks, KREBSBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KREBS BIOCHEMICALS & IND stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KREBS BIOCHEMICALS & IND technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KREBS BIOCHEMICALS & IND stock shows the neutral signal. See more of KREBS BIOCHEMICALS & IND technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.